As of Aug 28
| +0.09 / +4.21%|
The 1 analysts offering 12-month price forecasts for Sequenom Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +34.53% increase from the last price of 2.23.
The current consensus among 4 polled investment analysts is to Hold stock in Sequenom Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.